Hutchison China MediTech Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

Date: July 15, 2014
Pages: 50
Price:
US$ 499.00
Hutchison China MediTech Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default), Hard Copy Mail Delivery (+US$ 140.00)
ID: H07FE97216BBEN
Leaflet:

Download PDF Leaflet

Hutchison China MediTech Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Hutchison China MediTech Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between Hutchison China MediTech Ltd. and its competitors. This provides our Clients with a clear understanding of Hutchison China MediTech Ltd. position in the Pharmaceuticals and Biotechnology Industry.

  • The report contains detailed information about Hutchison China MediTech Ltd. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
  • Another part of the report is a SWOT-analysis carried out for Hutchison China MediTech Ltd.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
  • The Hutchison China MediTech Ltd. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
  • In the part that describes Hutchison China MediTech Ltd. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
  • Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Hutchison China MediTech Ltd. business.

About Hutchison China MediTech Ltd.

Hutchison China MediTech Limited, together with its subsidiaries, engages in the research, development, manufacture, distribution, and sale of prescription and over-the-counter pharmaceuticals, health supplements, and other consumer health and personal care products derived from traditional Chinese medicine (TMC) and botanical ingredients in the People’s Republic of China, the United Kingdom, and France. Its products comprise botanical, semi-synthetic natural product drugs and small molecule drugs for use in the oncology and auto-immune therapeutic areas; and botanical, natural, and organic food and personal care products. The company’s research and development pipeline include a Phase III clinical trail product, HMPL-004, for the treatment of Ulcerative Colitis; HMPL-011, a Phase I clinical trial product for the treatment of oncology and inflammation; HMPL-012 and HMPL-013, the pre-clinical stage oncology drugs; and HMPL-813 and HMPL-309, the late-preclinical stage products. It also offers various consumer products for traditional Chinese medicines and treatments, food and beverage, and skin and body care products under the ‘Sen’ brand name through its own network of retail stores. The company has joint venture agreements with Hutchison Baiyunshan, Shanghai Hutchison Pharmaceuticals, and Hutchison Healthcare for the development, manufacture, and marketing of both prescription and over-the-counter TCM pharmaceuticals and health food products; and The Hain Celestial Group, Inc. to market and distribute infant and toddler feeding products. It has strategic alliances with Eli Lilly and Company; and Ortho-McNeil-Janssen Pharmaceuticals, Inc. The company was founded in 2000 and is based in Hong Kong, Hong Kong. Hutchison China MediTech Limited operates as a subsidiary of Hutchison Healthcare Holdings Limited.


RESEARCH METHODOLOGY

DISCLAIMER

1. HUTCHISON CHINA MEDITECH LTD. COMPANY PROFILE

1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History

2. HUTCHISON CHINA MEDITECH LTD. BUSINESS OVERVIEW

2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units

3. HUTCHISON CHINA MEDITECH LTD. SWOT ANALYSIS

3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats

4. HUTCHISON CHINA MEDITECH LTD. FINANCIAL ANALYSIS

4.1. Financial Statements
  4.1.1. Income Statement
  4.1.2. Balance Sheet
  4.1.3. Cash Flow
4.2. Financial Ratios
  4.2.1. Profitability
  4.2.2. Margin Analysis
  4.2.3. Asset Turnover
  4.2.4. Credit Ratios
  4.2.5. Long-Term Solvency
  4.2.6. Growth Over Prior Year
  4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot

5. HUTCHISON CHINA MEDITECH LTD. COMPETITORS AND INDUSTRY ANALYSIS

5.1. Hutchison China MediTech Ltd. Direct Competitors
5.2. Comparison of Hutchison China MediTech Ltd. and Direct Competitors Financial Ratios
5.3. Comparison of Hutchison China MediTech Ltd. and Direct Competitors Stock Charts
5.4. Hutchison China MediTech Ltd. Industry Analysis
  5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
  5.4.2. Hutchison China MediTech Ltd. Industry Position Analysis

6. HUTCHISON CHINA MEDITECH LTD. NEWS & EVENTS

6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events

7. HUTCHISON CHINA MEDITECH LTD. EXPERTS REVIEW1

7.1. Experts Opinion
7.2. Experts Estimates

8. HUTCHISON CHINA MEDITECH LTD. ENHANCED SWOT ANALYSIS2

9. HUTCHISON CHINA MEDITECH LTD. PESTEL ANALYSIS2

9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors

10. HUTCHISON CHINA MEDITECH LTD. PORTER FIVE FORCES ANALYSIS2

11. HUTCHISON CHINA MEDITECH LTD. VRIO ANALYSIS2


APPENDIX 1: RATIO DEFINITIONS


LIST OF TABLES

Hutchison China MediTech Ltd. Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Hutchison China MediTech Ltd. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Hutchison China MediTech Ltd. Major Shareholders
Hutchison China MediTech Ltd. History
Hutchison China MediTech Ltd. Products
Revenues by Product
Revenues by Region
Hutchison China MediTech Ltd. Offices and Representations
Hutchison China MediTech Ltd. SWOT Analysis
Income Statement 2010-2013 Including 4-years Trends
Income Statement Latest 4 Quarters Including Trends
Balance Sheet 2010-2013 Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Cash Flow 2010-2013 Including Trends
Cash Flow Latest 4 Quarters Including Trends
Hutchison China MediTech Ltd. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Hutchison China MediTech Ltd. Capital Market Snapshot
Hutchison China MediTech Ltd. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Pharmaceuticals and Biotechnology Industry Statistics
Hutchison China MediTech Ltd. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Hutchison China MediTech Ltd. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Historical Surprises1
Revenue Estimates Trend1
Earnings Estimates Trend1
Revenue Revisions1
Enhanced SWOT Analysis2
Porter Five Forces Analysis2

LIST OF FIGURES

Hutchison China MediTech Ltd. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Hutchison China MediTech Ltd. 1-year Stock Charts
Hutchison China MediTech Ltd. 5-year Stock Charts
Hutchison China MediTech Ltd. vs. Main Indexes 1-year Stock Chart
Hutchison China MediTech Ltd. vs. Direct Competitors 1-year Stock Charts
Hutchison China MediTech Ltd. Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for public traded companies.

The above Company Fundamental Report is a half-ready report.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get up-to-date version for the same price. Please note that preparation of additional types of analyses requires extra time.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

  • How to use the strengths to take advantage of the opportunities?
  • How to use the strengths to reduce likelihood and impact of the threats?
  • How to overcome the weaknesses that obstruct taking advantage of the opportunities?
  • How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a Project Plan to improve its business performance.


PESTEL Analysis

PESTEL (also termed as STEP, PESTLE, STEEP, STEEPLE, STEEPLED, etc.) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

  • Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
  • Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
  • Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
  • Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
  • Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
  • Legal – What laws and legislations will exert influence on the style the business is carried out?

Porter Five Forces Analysis

The extended Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions followed by sixth question added to the original concept:

  1. What composes a threat of substitute products and services?
  2. Is there a threat of new competitors entering the market?
  3. What is the intensity of competitive rivalry?
  4. How big is the bargaining power of buyers?
  5. How significant is the bargaining power of suppliers?
  6. Is there any complementary products, government decisions or public perception that can impact business?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

  • Tangible resources
    • Financial
    • Physical
    • Technological
    • Organizational
  • Intangible resources
    • Human
    • Innovation and Creativity
    • Reputation
  • Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

  • Valuable?
  • Rare?
  • Costly to Imitate?
  • Organized Properly?

Ask Your Question

Hutchison China MediTech Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: